Investor Type | Firm |
Type of Fund | VC |
Industries | Education • BioTech • AgroTech • FinTech (& Financials services) • Medical Devices (& Hospital Services) • Healthcare (& Wellness) • Pharmaceutical (& Medicine) |
Stages | Early,Seed,Later, Pre-seed |
Investing | United States • United Kingdom • Australia • New Zealand |
Investment Range | $100,000 - $5,000,000 |
Investment Sweet Spot | $1,500,000 |
Assets Under Management | $404,500,000 |
Brandon Capital Partners is a venture capital firm rooted in Melbourne, Australia, specializing in providing seed, early-stage, and later-stage investment to companies within distinct industry sectors. With a focus on pharmaceuticals, biotechnology, healthcare devices and supplies, life sciences, digital health, HealthTech, and oncology, as well as a keen interest in manufacturing sectors in Australia and New Zealand, they operate with a clear commitment to innovation and excellence in the medical field. Their investment philosophy is centered around supporting life science companies from the initial proof-of-concept phase through to commercialization. They emphasize the creation of value not only for their portfolio companies but also for their investors and the broader patient community by driving medical advances in treatment and care. Brandon Capital manages assets totaling approximately $404.5 million and tailors investments to fit various stages of company growth, with a minimum investment of $100,000, a preference ('sweet spot') for deals around $1,500,000, and a maximum investment threshold of $5,000,000. Additionally, their investment specialties include early, seed, later, and pre-seed funding rounds. The firm sustains active portfolio companies and maintains relationships with investors and venture partners across Australia, New Zealand, the United States, and the United Kingdom. They have also been instrumental in founding several of their current investments, reflecting a pattern of being an initial backer in the ventures they believe in. Furthermore, Brandon Capital Partners has engaged in successful fund-raising efforts leading to a series of funds covering various stages of the life science venture investing spectrum. They promote the use of co-investment strategies with their investors to provide substantial support capacity to their portfolio, emphasizing long-term partnerships with entrepreneurs to facilitate the development and commercialization of their technologies.